Holen Sie sich die Stockscreener-App
3.65
2.14%
-0.08
Handel nachbörslich:
3.71
0.06
+1.64%
Prime Medicine Inc Aktie (PRME) Neueste Nachrichten
Earnings Report: Is Prime Medicine Inc backed by strong institutional buyingWeekly Investment Report & Free Community Supported Trade Ideas - baoquankhu1.vn
Prime Medicine (NASDAQ:PRME) Shares Gap UpHere's Why - MarketBeat
Prime Medicine (NYSE:PRME) Shares Gap UpShould You Buy? - MarketBeat
Prime Medicine (NYSE:PRME) Earns Outperform Rating from Analysts at Oppenheimer - MarketBeat
Prime Medicine (NASDAQ:PRME) Trading Down 6.3%Here's What Happened - MarketBeat
Prime Medicine (NYSE:PRME) Shares Down 6.9%Here's What Happened - MarketBeat
Prime Medicine (PRME) Focuses on Liver Franchise With $191.4M Cash Runway - Finviz
Will Prime Medicine Inc. stock outperform value stocksPrice Action & Technical Confirmation Alerts - Naître et grandir
Will Prime Medicine Inc. stock benefit from upcoming earnings reportsJuly 2025 Update & Growth Focused Entry Reports - Naître et grandir
LifeSci Capital initiates Prime Medicine (PRME), highlights one-and-done potential in liver and lung diseases - MSN
Guidance Update: Will Prime Medicine Inc stock hit new highs in YEARPortfolio Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Prime Medicine, Inc. (NYSE:PRME) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Prime Medicine, Inc. Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
Lifesci Capital Predicts Prime Medicine FY2025 Earnings - MarketBeat
Prime Medicine, Inc. $PRME Shares Acquired by ARK Investment Management LLC - MarketBeat
Prime Medicine, Inc. $PRME Stock Position Increased by Amova Asset Management Americas Inc. - MarketBeat
Citizens reiterates Prime Medicine stock rating on PM359 pathway By Investing.com - Investing.com Australia
Prime Medicine (NASDAQ:PRME) Upgraded by Lifesci Capital to "Strong-Buy" Rating - MarketBeat
Prime Medicine (PRME) Quarterly Loss Near US$50 Million Reinforces Bearish Community Narratives - simplywall.st
Prime Medicine unveils full year 2025 financial results and business update as progress advances - Traders Union
Prime Medicine, Inc. (PRME) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates - Bitget
Prime Medicine Reports 2025 Results, Advances Gene Editing Pipeline - TipRanks
Prime Medicine 2025 Net Loss Narrows as Revenue Rises -- Shares Fall Pre-Bell - marketscreener.com
Earnings Flash (PRME) Prime Medicine Posts 2025 Total Revenue $4.6M, vs. FactSet Est of $5.7M - marketscreener.com
Earnings Flash (PRME) Prime Medicine Posts 2025 Net Loss $1.35 a Share, vs. FactSet Est of $1.30 Loss - marketscreener.com
Prime Medicine : March 2026 Corporate Presentation - marketscreener.com
Prime Medicine 2025 net loss widens, hurt by higher R&D expenses - TradingView
Prime Medicine (Nasdaq: PRME) details 2025 results, cash runway and gene-editing milestones - Stock Titan
PRME Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Prime Medicine, Inc. (PRME) Announces Fourth Quarter Loss, Falls Short of Revenue Projections - Bitget
Investment Report: What is the target price for Prime Medicine Inc stockJuly 2025 Fed Impact & Low Risk High Reward Trade Ideas - baoquankhu1.vn
HighTower Advisors LLC Buys 312,401 Shares of Prime Medicine, Inc. $PRME - MarketBeat
Stock Traders Buy Large Volume of Call Options on Prime Medicine (NYSE:PRME) - MarketBeat
Prime Medicine to Participate in Upcoming Investor Conferences - Bitget
Prime Medicine (NYSE:PRME) Trading 10.3% HigherStill a Buy? - MarketBeat
PRME (Prime Medicine) PB Ratio : 3.72 (As of Feb. 23, 2026) - GuruFocus
Prime Medicine (NASDAQ:PRME) Trading Up 1.2%Here's What Happened - MarketBeat
Jacob Funds Bets on Prime Medicine (PRME), a Next-Generation Gene Therapy Company - Insider Monkey
Prime Medicine, Inc. $PRME Shares Acquired by Alphabet Inc. - MarketBeat
Aug Catalysts: Is Seacoast Banking Corporation of Florida impacted by rising rates2025 Market Outlook & Weekly Watchlist of Top Performers - baoquankhu1.vn
Should I average down on Prime Medicine Inc. stockWeekly Investment Recap & Reliable Price Breakout Alerts - mfd.ru
Aug Analyst Calls: Is Prime Medicine Inc stock a smart retirement pick2025 Biggest Moves & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Prime Medicine, Inc. (NYSE:PRME) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Earnings Miss: Will Prime Medicine Inc stock hit new highs in YEARJuly 2025 Spike Watch & AI Driven Price Forecasts - baoquankhu1.vn
Prime Medicine Advances Wilson Disease Pipeline With New Prescreening Study - TipRanks
Institutional Owners May Ignore Prime Medicine, Inc.'s (NASDAQ:PRME) Recent US$66m Market Cap Decline as Longer-term Profits Stay in the Green - 富途牛牛
Institutional investors in Prime Medicine, Inc. (NASDAQ:PRME) see US$110m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st
What is the target price for Prime Medicine Inc. stockJuly 2025 Weekly Recap & Verified Trade Idea Suggestions - mfd.ru
Aug Selloffs: Should I average down on Prime Medicine Inc stockJuly 2025 Drop Watch & Intraday High Probability Setup Alerts - baoquankhu1.vn
Favourable Signals For Prime Medicine: Numerous Insiders Acquired Stock - Yahoo Finance
Prime Medicine (NASDAQ:PRME) Shares Down 5.6%What's Next? - MarketBeat
Prime Medicine (NYSE:PRME) Trading Down 5.5%What's Next? - MarketBeat
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):